Clinical Trial Update: Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating the safety and efficacy of PRI-002 in patients with mild cognitive impairment due to Alzheimer's disease and early-onset Alzhei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Early-onset
• Cognitive Impairment Due to Alzheimer Disease

Drugs mentioned

• PRI-002

Snippet

Sponsor: PRInnovation GmbH | Conditions: Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset | Phase 2 | Status: ACTIVE_NOT_RECRUITING